BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11555572)

  • 1. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
    Buzdar A; Howell A
    Clin Cancer Res; 2001 Sep; 7(9):2620-35. PubMed ID: 11555572
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroidal aromatase inhibitors in elderly patients.
    Bajetta E; Zilembo N; Bichisao E; Pozzi P; Toffolatti L
    Crit Rev Oncol Hematol; 2000 Feb; 33(2):137-42. PubMed ID: 10737375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
    Tominaga T; Adachi I; Sasaki Y; Tabei T; Ikeda T; Takatsuka Y; Toi M; Suwa T; Ohashi Y
    Ann Oncol; 2003 Jan; 14(1):62-70. PubMed ID: 12488294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aromatase inhibitors: a review of clinical trials].
    Kerbrat P; Lefeuvre C
    Bull Cancer; 2000 Dec; 87 Spec No():31-39. PubMed ID: 11250606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preclinical evaluation of aromatase inhibitors antitumor activity].
    Auvray P; Bichat F; Genne P
    Bull Cancer; 2000 Dec; 87 Spec No():7-22. PubMed ID: 11250604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors: past, present and future in breast cancer therapy.
    Dutta U; Pant K
    Med Oncol; 2008; 25(2):113-24. PubMed ID: 17973095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aromatase inhibitors for treatment of advanced breast cancers].
    Sonoo H
    Nihon Rinsho; 2000 Apr; 58 Suppl():322-7. PubMed ID: 11026013
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aromatase inhibitors].
    Feutrie ML; Bonneterre J
    Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anastrozole for metastatic breast cancer.
    Med Lett Drugs Ther; 1996 Jul; 38(978):61-2. PubMed ID: 8668098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aromatase inhibitors in adjuvant setting in breast cancer].
    Spano JP; Khayat D; Delozier T
    Bull Cancer; 2004 Dec; 91 Suppl 4():S239-43. PubMed ID: 15899615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aromatase inhibitors in the treatment of breast cancer].
    Perey L
    Rev Med Suisse Romande; 2000 Jun; 120(6):495-500. PubMed ID: 11014093
    [No Abstract]   [Full Text] [Related]  

  • 12. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
    Pérez N; Borja J
    J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
    Hamilton A; Volm M
    Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
    Buzdar AU; Robertson JF; Eiermann W; Nabholtz JM
    Cancer; 2002 Nov; 95(9):2006-16. PubMed ID: 12404296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endometriosis and aromatase inhibitor].
    Takayama K; Bulun SE
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():157-60. PubMed ID: 11235156
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of aromatase inhibitors in the management of breast cancer.
    Baum M; Buzdar A
    Surg Clin North Am; 2003 Aug; 83(4):973-94. PubMed ID: 12875605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
    Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
    J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole in breast cancer.
    Hietanen P; Mäkelä M
    N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971057
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiaromatase agents: evolving role in adjuvant therapy.
    Jones SE
    Clin Breast Cancer; 2002 Apr; 3(1):33-42. PubMed ID: 12020394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors in the treatment of advanced breast cancer.
    Miller WR
    Cancer Treat Rev; 1989 Jun; 16(2):83-93. PubMed ID: 2527597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.